Free Trial
→ “Amazon Coin” set to outperform Bitcoin (From True Market Insiders) (Ad) Free QNTM Stock Alerts

Quantum Biopharma (QNTM) SEC Filings & 10K Form

Quantum Biopharma logo
$4.54 -0.05 (-1.09%)
Closing price 03/12/2025 04:00 PM Eastern
Extended Trading
$4.65 +0.11 (+2.42%)
As of 03/12/2025 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Quantum Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
02/26/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
9:18 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
6:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
3:00 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
6:31 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
7:30 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2025
7:32 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
8:16 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
6:22 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
6:31 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
6:54 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
7:50 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
6:32 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
7:09 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:27 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
6:39 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
8:22 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
8:46 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:20 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 424B5
08/26/2024
5:18 AM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
4:18 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K/A
08/15/2024
7:15 PM		Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:07 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
5:13 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
5:15 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K/A
08/12/2024
5:03 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
6:30 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
8:04 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2024
4:16 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2024
2:20 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
6:49 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
6:34 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
6:31 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
7:28 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
6:30 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
7:15 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
3:51 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
05/15/2024
5:02 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
7:31 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:33 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
6:49 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
7:03 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
3:57 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2024
8:22 PM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2024
7:01 AM		FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:QNTM) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Alert: DOGE goes live
Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...
Altimetry | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Forget Trump’s Tariffs, This March Event Is Bigger
While everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...
Brownstone Research | Sponsored